Skip to main content
Equibles
WAT logo

WAT · Waters Corp /De/ · Metrics

Track WAT — free

Use WAT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WAT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$442.83 +8.56 (+1.97%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$43.40B
Shares
98.25M
Volume · Oct 20 774.32K Avg daily vol (3M) 808.64K

WAT metrics

94 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$434.27
Market cap
$43.40B

Price action

20 metrics
Price change (1W)
+0.5%
Price change (30D)
+2.4%
Price change (3M)
+21.5%
Price change (6M)
+29.4%
Price change (YTD)
+14.3%
Price change (1Y)
+29.8%
Trailing year
Price change (5Y)
+24.2%
52-week high
$444.15
52-week low
$283.32
Change from 52-week high
-2.2%
Change from 52-week low
+53.3%
Annualized volatility
35.2%
Annualized volatility (3M)
26.9%
Beta
0.9
RSI (14D)
53.8
Price vs SMA 50
+3.1%
Price vs SMA 200
+18.5%
Avg volume (3M)
808,640
Relative volume
0.6
Average dollar volume
$332.35M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
98.25M

Valuation

12 metrics
P / E (TTM)
108.3
Trailing earnings · reciprocal yield 0.9%
PEG ratio
—
EV / revenue
10.2×
reciprocal yield 9.8%
EV / EBITDA
—
EV / EBIT
144.0×
reciprocal yield 0.7%
P / sales
9.2×
reciprocal yield 10.8%
P / book
2.8
reciprocal yield 35.4%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
78.1
reciprocal yield 1.3%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
31.6×
reciprocal yield 3.2%
P / E historical average (5Y)
31.2×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
7.8×
reciprocal yield 12.9%
EV / revenue historical average (5Y)
7.4×
reciprocal yield 13.5%
EV / EBIT historical average (3Y)
42.7×
reciprocal yield 2.3%
EV / EBIT historical average (5Y)
35.1×
reciprocal yield 2.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
7.1%
Trailing 12 months
Net margin
20.3%
Gross profit (TTM)
$1.23B
Operating profit (TTM)
$329.63M
Net income (TTM)
$166.63M
Trailing 12 months
Diluted EPS (TTM)
$4.01
FCF margin
—
Effective tax rate
19.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$29.05
Gross profit per diluted share (TTM)
$15.01
Operating profit per diluted share (TTM)
$7.75
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$1.69
Stock compensation per diluted share (TTM)
—
Book value per share
$43.02

Growth

11 metrics
Revenue growth YoY
+113.3%
Year over year
Net income growth YoY
-192.5%
Revenue (TTM)
$4.64B
Trailing 12 months
EPS growth YoY
-156.3%
Shares change YoY
+164,517.1%
Year over year · more shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+6.0%
EPS CAGR (3Y)
-2.8%
EPS CAGR (5Y)
+5.2%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.1%
Return on assets
0.7%
Debt / equity
0.3
Current ratio
1.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
2.2
Net debt / EBITDA
—
Return on invested capital
1.4%
Trailing 12 months
Net cash
−$4.55B
Latest balance sheet
Cash & equivalents
$539.00M
Total assets
$24.75B
Total debt
$5.09B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$549.55M
Capital expenditures (TTM)
$150.75M
R&D (TTM)
$318.54M
SG&A (TTM)
$1.25B
Stock compensation (TTM)
$73.13M
R&D / revenue
6.9%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1,187
13F filer change QoQ
+6
Institutional ownership
100.1%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
29.0%
Private-fund adviser ownership
27.9%
Active holders' share change QoQ
+5.2%
Holder tenure
16.6
Price vs estimated holder cost
+11.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.8%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.44M
Insider-sentiment score
43 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1000697 CUSIP 941848103 13F (30d) 191 filings 186 filers Visit website Investor relations